Johnson & Johnson vaccine could be approved by mid-March

Ireland would be entitled to 2.2 million doses of the single-shot vaccine

16th February, 2021
Johnson & Johnson vaccine could be approved by mid-March
The new vaccine, developed by Johnson & Johnson subsidiary Janssen, would be the fourth vaccine available in Europe. Picture: Getty

A new Covid-19 vaccine from Johnson & Johnson could be approved in Europe as early as mid-March following an application for authorisation to the European Medicines Agency (EMA) on Tuesday.

The new vaccine, developed by Johnson & Johnson subsidiary Janssen, would be the fourth vaccine available in Europe, but the first one that requires just a single dose.

The European Commission has ordered 200 million doses of the vaccine, of which Ireland will be entitled...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Government should begin delayed dosing programme this week, O‘Neill says

Tony O’Brien: Our quarantine approach seems designed with failure in mind

Exemption to hotel quarantine sought for ‘essential’ engineers by business groups

Danielle Barron on Covid-19: Celebrations across the water - are we nearly there yet?